• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-辛基环戊酮抑制耐β-内酰胺类糖尿病伤口病原菌。

2-Octylcyclopentanone Inhibits Beta Lactam Resistant Diabetic Wound Pathogens.

作者信息

Rozman Nur Amiera Syuhada, Yenn Tong Woei, Ring Leong Chean, Ab Rashid Syarifah, Wen-Nee Tan, Lim Jun Wei

机构信息

Universiti Kuala Lumpur, Branch Campus Malaysian Institute of Chemical and Bioengineering Technology, Lot 1988 Kawasan Perindustrian Bandar Vendor, Taboh Naning, 78000 Alor Gajah, Melaka, Malaysia.

Universiti Kuala Lumpur - Institute of Medical Science Technology, A1, 1, Jalan TKS 1, Taman Kajang Sentral, 43000 Kajang, Selangor.

出版信息

Trop Life Sci Res. 2023 Mar;34(1):279-291. doi: 10.21315/tlsr2023.34.1.15. Epub 2023 Mar 31.

DOI:10.21315/tlsr2023.34.1.15
PMID:37065798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10093773/
Abstract

Microbial infection is a frequent complication of diabetic foot ulcers, with up to 82% of ulcers being infected at the initial stage of diabetes. Furthermore, the emergence of beta lactam resistant pathogens managed to eliminate the use of beta lactam antibiotics as a chemotherapeutic alternative. This further increases the amputation and mortality rate. Hence, the aim of this study is to evaluate antimicrobial efficacy of a ketone derivative 2-octylcyclopentanone against diabetic wound pathogens. The inhibitory activity of the compound was determined using disc diffusion and broth microdilution assay. Generally, 2-octylcyclopentanone showed broad-spectrum antimicrobial activity, particularly against beta lactam resistant pathogens. The compound showed comparably better antimicrobial activity than all reference antibiotics, including chloramphenicol, streptomycin, ampicillin and penicillin. In addition, the same compound also inhibits a clinically isolated that was resistant to all reference antibiotics. The activity was microbicidal based on the low minimal lethality concentration recorded, particularly on MRSA, and . The killing efficiency of the compound was concentration dependent. During kill curve analysis, the inhibitory activity of 2-octylcyclopentanone was concentration and time-dependent. 99.9% of reduction of bacterial growth was observed. MRSA and , two significant diabetic wound infections, are totally inhibited by the molecule at a concentration of minimum lethality concentration. In short, 2-octylcyclopentanone exhibited significant inhibitory towards wide range of diabetic wound pathogens. Which is considered crucial since it will provide a safe and effective alternative treatment for diabetic ulcer infection.

摘要

微生物感染是糖尿病足溃疡常见的并发症,在糖尿病初期,高达82%的溃疡会受到感染。此外,β-内酰胺耐药病原体的出现使得β-内酰胺类抗生素作为化疗药物的选择不再可行。这进一步增加了截肢率和死亡率。因此,本研究旨在评估酮衍生物2-辛基环戊酮对糖尿病伤口病原体的抗菌效果。使用纸片扩散法和肉汤微量稀释法测定该化合物的抑制活性。总体而言,2-辛基环戊酮具有广谱抗菌活性,尤其对β-内酰胺耐药病原体。该化合物显示出比所有参考抗生素(包括氯霉素、链霉素、氨苄西林和青霉素)更好的抗菌活性。此外,该化合物还能抑制一株对所有参考抗生素均耐药的临床分离菌。基于所记录的低最低致死浓度,该活性具有杀菌作用,特别是对耐甲氧西林金黄色葡萄球菌(MRSA)以及[此处原文缺失一种细菌名称]。该化合物的杀菌效率呈浓度依赖性。在杀菌曲线分析中,2-辛基环戊酮的抑制活性呈浓度和时间依赖性。观察到细菌生长减少了99.9%。MRSA以及[此处原文缺失一种细菌名称]这两种严重的糖尿病伤口感染,在最低致死浓度下被该分子完全抑制。简而言之,2-辛基环戊酮对多种糖尿病伤口病原体表现出显著的抑制作用。鉴于它将为糖尿病溃疡感染提供一种安全有效的替代治疗方法,这一点至关重要。

相似文献

1
2-Octylcyclopentanone Inhibits Beta Lactam Resistant Diabetic Wound Pathogens.2-辛基环戊酮抑制耐β-内酰胺类糖尿病伤口病原菌。
Trop Life Sci Res. 2023 Mar;34(1):279-291. doi: 10.21315/tlsr2023.34.1.15. Epub 2023 Mar 31.
2
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.亚最低抑菌浓度美罗培南和环丙沙星对糖尿病足溃疡患者广泛耐药(XDR)铜绿假单胞菌分离株的疗效。
Infect Genet Evol. 2021 Aug;92:104824. doi: 10.1016/j.meegid.2021.104824. Epub 2021 Mar 25.
3
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.糖尿病足感染中金黄色葡萄球菌生物膜的药敏模式
BMC Microbiol. 2016 Jun 23;16(1):119. doi: 10.1186/s12866-016-0737-0.
4
Bacteriological Profile of Diabetic Foot Ulcers and Detection of Methicillin-Resistant Staphylococcus aureus and Extended-Spectrum β-Lactamase Producers in a Tertiary Care Hospital.三级护理医院中糖尿病足溃疡的细菌学特征以及耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶菌株的检测
Cureus. 2021 Dec 22;13(12):e20596. doi: 10.7759/cureus.20596. eCollection 2021 Dec.
5
Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection.吲哚菁绿和乙二胺四乙酸介导的抗菌光动力疗法联合抗生素对糖尿病足感染耐药菌生物膜的协同体外作用。
Photodiagnosis Photodyn Ther. 2019 Mar;25:300-308. doi: 10.1016/j.pdpdt.2019.01.010. Epub 2019 Jan 8.
6
Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia.来自埃塞俄比亚亚的斯亚贝巴选定医院的糖尿病足溃疡细菌分离株及其抗菌药物耐药谱。
Front Endocrinol (Lausanne). 2022 Aug 31;13:987487. doi: 10.3389/fendo.2022.987487. eCollection 2022.
7
Diagnosis and treatment of diabetic foot infections.糖尿病足感染的诊断与治疗
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S. doi: 10.1097/01.prs.0000222737.09322.77.
8
Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant .木犀草素增强氨基糖苷类和β-内酰胺类抗生素对耐甲氧西林菌的作用。
Exp Ther Med. 2016 Jun;11(6):2597-2601. doi: 10.3892/etm.2016.3212. Epub 2016 Mar 31.
9
New erythromycin derivatives enhance β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.新型红霉素衍生物增强β-内酰胺类抗生素对耐甲氧西林金黄色葡萄球菌的抗菌作用。
Lett Appl Microbiol. 2015 Apr;60(4):352-8. doi: 10.1111/lam.12378. Epub 2015 Jan 14.
10
[Analysis of distribution and drug resistance of pathogens isolated from 541 hospitalized children with burn infection].[541例烧伤感染住院患儿病原菌分布及耐药性分析]
Zhonghua Shao Shang Za Zhi. 2016 Nov 20;32(11):670-675. doi: 10.3760/cma.j.issn.1009-2587.2016.11.008.

本文引用的文献

1
A neglected causative agent in diabetic foot infection: a retrospective evaluation of 13 patients with fungal etiology.被忽视的糖尿病足感染致病因素:13 例真菌感染病因的回顾性评估。
Turk J Med Sci. 2019 Feb 11;49(1):81-86. doi: 10.3906/sag-1809-74.
2
Antibacterial and antifungal activities of pyroligneous acid from wood of Eucalyptus urograndis and Mimosa tenuiflora.桉树木材和含羞草木醋液的抑菌和抗真菌活性。
J Appl Microbiol. 2018 Jan;124(1):85-96. doi: 10.1111/jam.13626. Epub 2017 Dec 19.
3
Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review.
糖尿病患者与非糖尿病患者下肢截肢发生率的系统评价。
PLoS One. 2017 Aug 28;12(8):e0182081. doi: 10.1371/journal.pone.0182081. eCollection 2017.
4
Interaction of Candida Species with the Skin.念珠菌属与皮肤的相互作用。
Microorganisms. 2017 Jun 7;5(2):32. doi: 10.3390/microorganisms5020032.
5
Effects of β-caryophyllene and Murraya paniculata essential oil in the murine hepatoma cells and in the bacteria and fungi 24-h time-kill curve studies.β-石竹烯和九里香精油在小鼠肝癌细胞以及细菌和真菌24小时时间杀菌曲线研究中的作用。
Pharm Biol. 2017 Dec;55(1):190-197. doi: 10.1080/13880209.2016.1254251.
6
Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes.来自肯尼亚植物的48种化合物对多重耐药表型的抗菌活性及构效关系
Springerplus. 2016 Jun 27;5(1):901. doi: 10.1186/s40064-016-2599-1. eCollection 2016.
7
Systemic antibiotics for treating diabetic foot infections.用于治疗糖尿病足感染的全身性抗生素。
Cochrane Database Syst Rev. 2015 Sep 4;2015(9):CD009061. doi: 10.1002/14651858.CD009061.pub2.
8
Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence.β-内酰胺酶阻遏蛋白BlaI调节金黄色葡萄球菌抗菌肽抗性和毒力。
PLoS One. 2015 Aug 25;10(8):e0136605. doi: 10.1371/journal.pone.0136605. eCollection 2015.
9
Human exposure to trace elements through the skin by direct contact with clothing: Risk assessment.人类通过与衣物直接接触经皮肤暴露于微量元素:风险评估。
Environ Res. 2015 Jul;140:308-16. doi: 10.1016/j.envres.2015.03.032. Epub 2015 Apr 16.
10
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.慢性伤口感染:铜绿假单胞菌和金黄色葡萄球菌的作用。
Expert Rev Anti Infect Ther. 2015 May;13(5):605-13. doi: 10.1586/14787210.2015.1023291. Epub 2015 Mar 8.